Bartolomé Moyá

4.0k total citations
51 papers, 3.2k citations indexed

About

Bartolomé Moyá is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Bartolomé Moyá has authored 51 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Medicine, 26 papers in Pharmacology and 19 papers in Molecular Biology. Recurrent topics in Bartolomé Moyá's work include Antibiotic Resistance in Bacteria (46 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Bacterial biofilms and quorum sensing (18 papers). Bartolomé Moyá is often cited by papers focused on Antibiotic Resistance in Bacteria (46 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Bacterial biofilms and quorum sensing (18 papers). Bartolomé Moyá collaborates with scholars based in Spain, United States and Australia. Bartolomé Moyá's co-authors include Carlos Juan, Laura Zamorano, Antonio Oliver, Antonio Oliver, Gabriel Cabot, José Luis Pérez, Jesús Blázquez, Xavier Mulet, Fé Tubau and Susanne Häußler and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and International Journal of Molecular Sciences.

In The Last Decade

Bartolomé Moyá

51 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartolomé Moyá Spain 32 2.7k 1.3k 1.1k 657 586 51 3.2k
Gabriel Cabot Spain 33 2.6k 1.0× 1.4k 1.1× 957 0.9× 523 0.8× 450 0.8× 57 3.1k
Laura Zamorano Spain 30 2.3k 0.9× 1.2k 0.9× 935 0.9× 549 0.8× 494 0.8× 67 2.9k
Alejandro Beceiro Spain 29 2.8k 1.0× 1.4k 1.0× 805 0.8× 1.1k 1.7× 560 1.0× 94 3.8k
José Manuel Rodríguez-Martínez Spain 33 2.9k 1.1× 922 0.7× 1.0k 1.0× 980 1.5× 706 1.2× 96 3.5k
Ørjan Samuelsen Norway 35 3.1k 1.2× 1.1k 0.8× 765 0.7× 1.4k 2.2× 638 1.1× 95 4.0k
Antonio Oliver Spain 24 1.8k 0.7× 973 0.7× 655 0.6× 386 0.6× 390 0.7× 39 2.2k
Katy Jeannot France 29 1.9k 0.7× 1.1k 0.8× 555 0.5× 486 0.7× 290 0.5× 73 2.4k
Magdalena A. Taracila United States 33 2.8k 1.1× 808 0.6× 1.5k 1.4× 786 1.2× 848 1.4× 75 3.5k
Carlos Juan Spain 42 4.2k 1.6× 2.4k 1.8× 1.3k 1.2× 1.2k 1.8× 760 1.3× 92 5.2k
Kalyan D. Chavda United States 29 2.5k 0.9× 657 0.5× 769 0.7× 1.0k 1.6× 486 0.8× 45 2.9k

Countries citing papers authored by Bartolomé Moyá

Since Specialization
Citations

This map shows the geographic impact of Bartolomé Moyá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartolomé Moyá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartolomé Moyá more than expected).

Fields of papers citing papers by Bartolomé Moyá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartolomé Moyá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartolomé Moyá. The network helps show where Bartolomé Moyá may publish in the future.

Co-authorship network of co-authors of Bartolomé Moyá

This figure shows the co-authorship network connecting the top 25 collaborators of Bartolomé Moyá. A scholar is included among the top collaborators of Bartolomé Moyá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartolomé Moyá. Bartolomé Moyá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jieqiang, Yuli Qian, Yinzhi Lang, et al.. (2024). Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial Agents and Chemotherapy. 68(3). e0139923–e0139923. 6 indexed citations
2.
Fraile-Ribot, Pablo A., Cristina Lasarte-Monterrubio, Bartolomé Moyá, et al.. (2024). Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 79(10). 2591–2597. 12 indexed citations
3.
Bulitta, Jürgen B., Phillip J. Bergen, Yinzhi Lang, et al.. (2023). Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula. Journal of Pharmaceutical Sciences. 113(1). 202–213. 2 indexed citations
4.
Oliver, Antonio, et al.. (2023). Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology. Antimicrobial Agents and Chemotherapy. 67(6). e0160322–e0160322. 6 indexed citations
5.
Docobo-Pérez, Fernando, et al.. (2023). Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae. Microbiology Spectrum. 11(3). e0069223–e0069223. 5 indexed citations
6.
7.
8.
Barceló, Isabel M., Gabriel Cabot, Prashant Joshi, et al.. (2021). In vitroevolution of cefepime/zidebactam (WCK 5222) resistance inPseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact onin vivoefficacy. Journal of Antimicrobial Chemotherapy. 76(10). 2546–2557. 23 indexed citations
9.
Gomis-Font, María A., Gabriel Cabot, Laura Zamorano, et al.. (2021). Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. Journal of Antimicrobial Chemotherapy. 77(4). 957–968. 21 indexed citations
10.
Gomis-Font, María A., Gabriel Cabot, Irina Sánchez-Diener, et al.. (2020). In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 75(9). 2508–2515. 37 indexed citations
11.
12.
Moyá, Bartolomé, Sachin Bhagwat, Gabriel Cabot, et al.. (2020). Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 75(6). 1474–1478. 40 indexed citations
13.
Torrens, Gabriel, Sara B. Hernández, Juan A. Ayala, et al.. (2019). Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling. mSystems. 4(6). 59 indexed citations
14.
Moyá, Bartolomé, Isabel M. Barceló, Gabriel Cabot, et al.. (2019). In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 63(5). 40 indexed citations
15.
Jiao, Yuanyuan, Bartolomé Moyá, Alexandre Prehn Zavascki, et al.. (2019). Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial Agents and Chemotherapy. 63(7). 21 indexed citations
16.
Sutaria, Dhruvitkumar S., Bartolomé Moyá, Kari B. Green, et al.. (2018). First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 62(6). 60 indexed citations
17.
Jiao, Yuanyuan, Tae‐Hwan Kim, Xun Tao, et al.. (2018). First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers. European Journal of Pharmaceutical Sciences. 123. 416–428. 8 indexed citations
18.
Moyá, Bartolomé, Isabel M. Barceló, Sachin Bhagwat, et al.. (2017). Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates. Antimicrobial Agents and Chemotherapy. 61(11). 66 indexed citations
19.
Torrens, Gabriel, Bartolomé Moyá, Laura Zamorano, et al.. (2017). Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system. PLoS ONE. 12(7). e0181932–e0181932. 30 indexed citations
20.
Mena, A., María D. Macià, Núria Borrell, et al.. (2007). Inactivation of the Mismatch Repair System in Pseudomonas aeruginosa Attenuates Virulence but Favors Persistence of Oropharyngeal Colonization in Cystic Fibrosis Mice. Journal of Bacteriology. 189(9). 3665–3668. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Cabot Breakdown of academic impact, for papers by Laura Zamorano Breakdown of academic impact, for papers by Alejandro Beceiro Breakdown of academic impact, for papers by José Manuel Rodríguez-Martínez Breakdown of academic impact, for papers by Ørjan Samuelsen Breakdown of academic impact, for papers by Antonio Oliver Breakdown of academic impact, for papers by Katy Jeannot Breakdown of academic impact, for papers by Magdalena A. Taracila Breakdown of academic impact, for papers by Carlos Juan Breakdown of academic impact, for papers by Kalyan D. Chavda
Rankless by CCL
2026